2025 Neonatal Neurocritical Care Reading List

Reading List

Please click below to access the 2025 Neonatal Neurocritical Care reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Identify the role of fetal vascular malperfusion placental lesions in the neurodevelopmental impairment of infants
• Explain the manner in which congenital infections contribute to fetal central nervous system abnormalities
• Recognize the importance of utilizing a two-pronged approach, simultaneous metabolic and molecular testing, to allow early and rapid identification of neurogenetic and metabolic diseases
• Appreciate the increased mortality and neurodevelopmental impairment in extremely preterm neonates who receive platelet transfusions

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry and Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved this activity as part of a comprehensive self-assessment (SA) CME activity, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of continuing certification.

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2025 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Neonatal Neurocritical Care Certification Examination Committee Contributors

Christopher D. Smyser, MD, Chair, Washington University SOM in St. Louis 
Disclosures: Received compensation as expert witness/legal consultation for the firm Hanna, Campbell & Powell in Akron, OH; receives research support from the National Institutes of Health and Gates Foundation. 

Alexa K. Craig, MD, MsC, MS, Vice Chair, Maine Medical Partners 
Disclosures: Receives compensation for providing neonatal neurology consultation services to the Univ of Massachusetts NICU and to the NICU in Cedar Rapids, Iowa known as Unity Point/St. Luke's through a business entity she started called Neuro Network for Newborns; receives compensation for EISAI-as a sitting member of a DSMB for a drug trial for epilepsy in children; receives research support from NIH for a COBRE grant project and also from HRSA for a telemedicine project.

Catherine J. Chu, MD, Harvard Medical School 
Disclosures: Receives compensation as a consultant from Biogen Inc, Ionis Pharmaceuticals, Ovid Pharmaceuticals, and Novartis; receives research support from NIH NINDS, NIMH, Epilepsy Foundation New England, Novartis, and American Epilepsy Society. 

Dawn L. Gano, MD, MAS, University of California San Francisco 
Disclosures: Received research funding from: NIH/NICHD, Cerebral Palsy Alliance Research Foundation, California Institute of Regenerative Medicine, and California Preterm Birth Initiative.

Terrie E. Inder, MD, Children’s Hospital of Orange County 
Disclosures: Receives compensation for scientific advising from Aspect Imaging and Realta; receives compensation for expert testimony for limited legal cases; Contributes to neonatal perinatal board certification exam writing as content expert with limited questions each year.

Sarah B. Mulkey, MD, PhD, Children’s National Hospital 
Disclosures: Serve as the principal investigator for a grant supported by the NIH and a Co-investigator for a grant supported by the NIH. The funding goes to her institution. It does provide salary support for efforts on the grant. She has a contract with the US Centers for Disease Control for technical expertise that provides salary support for her effort. Receives salary support from the Steven and Alexandra Lyme Foundation through the Clinical Trials Network for research on Lyme disease. 

Andrea C. Pardo, MD, Northwestern University Feinberg School of Medicine 
Disclosures: Receives compensation as Guest Editor- Clinics of Perinatology (Neonatal Neurocritical Care issue)- Elsevier Section Editor- Current opinion in Pediatrics (Neurology Section)- Wolters Kluwer Health; Holds stock options in: Allyx Inc- 10K, Celldom Inc- 10K, and Saccharo Inc- 10K; receives research support as site PI for retrospective chart review for use of lacosamide in neonates with seizures. Sponsored by UCB. Investigator initiated study (PI Soul) $500 to institution (Lurie Children's); Chair of Child Neurology Society maintenance of certification committee- tasked with development of self-assessment examinations as part of the committee. 

Anna A. Penn, MD, PhD, Columbia University Dept. of Pediatrics 
Disclosures: Receives research support from NIH R01 and R21 support; SFARI grant support.

Mark S. Scher, MD, University Hospitals Case Medical Center 
Disclosures: Nothing to disclose.

Emily Wing Yun Tam, MDCM, MAS, Hospital for Sick Children 
Disclosures: Received compensation as expert witness in a legal case, retained by Carbert Waite LLP; Research grant funding (PI) from Canadian Institutes of Health Research. - Research grant funding (PI) from National Institutes of Health. - Research grant funding (site co-I) from UCB Biopharma SRL); Non-compensation participation at Society for Pediatric Research, elected councillor. - Newborn Brain Society, education committee member. - Co-Chair, Area of Focused Competency in Neonatal Neurocritical Care, Royal College of Physicians and Surgeons of Canada.

Charu Venkatesan, MD, PhD, Cincinnati Children’s Hospital 
Disclosures: Nothing to disclose. 

Michael D. Weiss, MD, UF Health Shands Children's Hospital 
Disclosures: Received compensation as a consultant for Belmont Medical Group; performed medical legal consulting as an expert witness for several law firms both for plaintiff and defense attorneys. Performed chart reviews and provided causation opinions; received research support NIH RO1 and an NIH SBIR with Meditrace. 

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326